ALLEGAN, Mich., May 2, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on June 18, 2013 to shareholders of record on May 31, 2013.
(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )
From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, pet health, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).
For further information: Arthur J. Shannon, Vice President, Investor Relations and Communication, (269) 686-1709, email@example.com, or Bradley Joseph, Senior Manager, Investor Relations and Communication, (269) 686-3373, firstname.lastname@example.org